Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) EBIT Margin (2016 - 2020)

Edesa Biotech's EBIT Margin history spans 8 years, with the latest figure at 826793.8% for Q3 2020.

  • For Q3 2020, EBIT Margin changed N/A year-over-year to 826793.8%; the TTM value through Jun 2021 reached 4466156.2%, down 446441937.0%, while the annual FY2020 figure was 1946.72%, N/A changed from the prior year.
  • EBIT Margin for Q3 2020 was 826793.8% at Edesa Biotech, down from 1607.89% in the prior quarter.
  • Across five years, EBIT Margin topped out at 752.65% in Q3 2018 and bottomed at 826793.8% in Q3 2020.
  • The 5-year median for EBIT Margin is 1607.89% (2020), against an average of 77832.92%.
  • The largest annual shift saw EBIT Margin tumbled -4767247bps in 2017 before it skyrocketed 26246291bps in 2020.
  • A 5-year view of EBIT Margin shows it stood at 997.12% in 2016, then tumbled by -580bps to 6784.2% in 2017, then soared by 111bps to 752.65% in 2018, then tumbled by -236bps to 1025.68% in 2019, then crashed by -80509bps to 826793.8% in 2020.
  • Per Business Quant, the three most recent readings for EDSA's EBIT Margin are 826793.8% (Q3 2020), 1607.89% (Q2 2020), and 1371.98% (Q1 2020).